All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: HIV Infections-32071061

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	32071061	A98G	RT	gag-pol	HIV Infections	D G R S L	View
2	32071061	D67N	RT	gag-pol	HIV Infections	D G R S L	View
3	32071061	E138A	RT	gag-pol	HIV Infections	D G R S L	View
4	32071061	E138G	RT	gag-pol	HIV Infections	D G R S L	View
5	32071061	E138K	RT	gag-pol	HIV Infections	D G R S L	View
6	32071061	E138Q	RT	gag-pol	HIV Infections	D G R S L	View
7	32071061	G190A	RT	gag-pol	HIV Infections	D G R S L	View
8	32071061	G190S	RT	gag-pol	HIV Infections	D G R S L	View
9	32071061	H221Y	RT	gag-pol	HIV Infections	D G R S L	View
10	32071061	K101E	RT	gag-pol	HIV Infections	D G R S L	View
11	32071061	K101H	RT	gag-pol	HIV Infections	D G R S L	View
12	32071061	K101P	RT	gag-pol	HIV Infections	D G R S L	View
13	32071061	K103N	RT	gag-pol	HIV Infections	D G R S L	View
14	32071061	K103S	RT	gag-pol	HIV Infections	D G R S L	View
15	32071061	K65R	RT	gag-pol	HIV Infections	D G R S L	View
16	32071061	K70R	RT	gag-pol	HIV Infections	D G R S L	View
17	32071061	L100I	RT	gag-pol	HIV Infections	D G R S L	View
18	32071061	M184I	RT	gag-pol	HIV Infections	D G R S L	View
19	32071061	M184V	RT	gag-pol	HIV Infections	D G R S L	View
20	32071061	M230L	RT	gag-pol	HIV Infections	D G R S L	View
21	32071061	M41L	RT	gag-pol	HIV Infections	D G R S L	View
22	32071061	P225H	RT	gag-pol	HIV Infections	D G R S L	View
23	32071061	Q480H	RT	gag-pol	HIV Infections	D G R S L	View
24	32071061	Q483L	RT	gag-pol	HIV Infections	D G R S L	View
25	32071061	V106I	RT	gag-pol	HIV Infections	D G R S L	View
26	32071061	V106M	RT	gag-pol	HIV Infections	D G R S L	View
27	32071061	V108I	RT	gag-pol	HIV Infections	D G R S L	View
28	32071061	V179D	RT	gag-pol	HIV Infections	D G R S L	View
29	32071061	V179F	RT	gag-pol	HIV Infections	D G R S L	View
30	32071061	V179T	RT	gag-pol	HIV Infections	D G R S L	View
31	32071061	V90I	RT	gag-pol	HIV Infections	D G R S L	View
32	32071061	Y115F	RT	gag-pol	HIV Infections	D G R S L	View
33	32071061	Y181C	RT	gag-pol	HIV Infections	D G R S L	View
34	32071061	Y181I	RT	gag-pol	HIV Infections	D G R S L	View
35	32071061	Y181V	RT	gag-pol	HIV Infections	D G R S L	View
36	32071061	Y188L	RT	gag-pol	HIV Infections	D G R S L	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.